PolyNovo is a disruptive ASX 200 medical technology company. Its products simplify managing acute complex wounds, redefining healing with differentiated outcomes across many etiologies. After treating 62,000+ patients across 46 countries, the company is investing for growth via new products, indicat...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
201-500 Employees
Year Founded:
2019 (7 years)
Address:
2/ 320LORIMER ST; PORT MELBOURNE, VICTORIA 3207, AU
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
HIGH
spending power
